Third filament diseases

Advances in Experimental Medicine and Biology

Volumn 642, Issue , 2008, Pages 99-115

  Udd, Bjarne ^a,b,c  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c VAASA CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTRANSFERASE;

ARTICLE; CHEMISTRY; GENETIC PREDISPOSITION; GENETICS; HUMAN; METABOLISM; MUSCLE DISEASE; PHENOTYPE; SKELETAL MUSCLE; ULTRASTRUCTURE;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUSCLE FIBERS, SKELETAL; MUSCULAR DISEASES; PHENOTYPE; PHOSPHOTRANSFERASES;

EID: 60549114317     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-84847-1_9     Document Type: Article

References (72)

1. Labeit S, Gautel M, Lakey A et al. Towards a molecular understanding of titin. EMBO J 1992; 11:1711-1716.
2. Labeit S, Kolmerer B. Titins: Giant proteins in charge of muscle ultrastructure and elasticity. Science 1995; 270:293-296.
3. Freiburg A, Gautel M. A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Eur J Biochem 1996; 235:317-323.
4. Gautel M, Mues A, Young P. Control of sarcomeric assembly: The flow of information on titin. Rev Physiol Biochem Pharmacol 1999; 38:97-137.
5. Improta S, Politou AS, Pastore A. Immunoglobulin-like modules from titin I-band: Extensible components of muscle elasticity. Structure 1996; 4:323-337.
6. Kolmerer B, Olivieri N, Witt CC et al. Genomic organization of M line titin and its tissue-specific expression in two distinct isoforms. J Mol Biol 1996; 256:556-563. (Pubitemid 26107205)
7. Hoshijima M. Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin and associated structures. Am J Physiol Heart Circ Physiol 2006; 290(4):H1313-25.
8. Witt SH, Labeit D, Granzier H et al. Dimerization of the cardiac ankyrin protein CARP: Implications for MARP titin-based signaling. J Muscle Res Cell Motil 2006; 1:1-8.
9. Lange S, Xiang F, Yakovenko A et al. The kinase domain of titin controls muscle gene expression and protein turnover. Science 2005; 308:1599-1603. (Pubitemid 40807503)
10. Bang M-L, Centner T, Fornoff F et al. The complete gene sequence of titin, expression of an unusual 700-kDa titin isoform and its interaction with obscurin identify a novel Z-line to I-band linking system. Circ Res 2001; 89:1065-1072. (Pubitemid 34640875)
11. Gautel M, Goulding D, Bullard B et al. The central Z-disk region of titin is assembled from a novel repeat in variable copy numbers. J Cell Sci 1996; 109:2747-2754. (Pubitemid 26388359)
12. Sorimachi H, Freiburg A, Kolmerer B et al. Tissue-specific expression and a-actinin binding properties of the Z-disc titin: Implications for the nature of vertebrate Z-discs. J Mol Biol 1997; 270:688-695. (Pubitemid 27332059)
13. Trombitas K, Wu Y, Labeit S et al. Cardiac titin isoforms are expressed in the half-sarcomere and extend independently. Am J Physiol Heart Circ Physiol 2001; 285:H1793-1799.
14. Wu Y, Bell SP, Trombitas K et al. Changes in titin isoform expression in pacing-induced cardiac failure give rise to increased passive muscle stiffness. Circulation 2002; 106:1384-1389. (Pubitemid 35013043)
15. Granzier H, Wu Y, Siegfried L et al. Titin: Physiological function and role in cardiomyopathy and failure. Heart Fail Rev 2005; 10(3):211-223. (Pubitemid 43115831)
16. Lange S, Agarkova I, Perriard JC et al. The sarcomeric M-band during development and in disease. J Muscle Res Cell Motil 2006; 10:1-5.
17. Ojima K, Ono Y, Doi N et al. Myogenic state, sarcomere length and protease activity modulate localization of muscle-specific calpain. J Biochem 2007; E-publ.
18. Richard I, Broux O, Allamand V et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 1995; 81:27-40.
19. Moreira ES, Wiltshire TJ, Faulkner G et al. Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nat Genet 2000; 24(2):163-166. (Pubitemid 30094717)
20. Gerull B, Gramlich M, Atherton J et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet 2002; 30:201-204.
21. Itoh-Satoh M, Hayashi T, Nishi H et al. Titin mutations as the molecular basis for dilated cardiomyopathy. Biochem Biophys Res Commun 2002; 291:385-393. (Pubitemid 34694417)
22. Hackman P, Vihola A, Haravuori H et al. Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. Am J Hum Genet 2002; 71:492-500. (Pubitemid 34970121)
23. Carmignac V, Salih MA, Quijano-Roy S et al. C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy. Ann Neurol 2007; 61(4):340-351. (Pubitemid 46676734)
24. Satoh M, Takahashi M, Sakamoto T et al. Structural analysis of the titin gene in hypertrophic cardiomyopathy: Identification of a novel disease gene. Bioch Biophys Res Commun 1999; 262:411-417. (Pubitemid 29429882)
25. Seidman JG, Seidmann C. The genetics basis for cardiomyopathy: From mutation identification to manifestation paradigms. Cell 2001, 104:557-567. (Pubitemid 32201950)
26. Gerull B, Atherton J, Geupel A et al. Identifififififififi cation of a novel frameshiftftftftftftft mutation in the giant muscle fififififififi lament titin in a large Australian family with dilated cardiomyopathy. J Mol Med 2006; 84(6):478-483. (Pubitemid 43801326)
27. Matsumoto Y, Hayashi T, Inagaki N et al. Functional analysis of titin/connectin N2-B mutations found in cardiomyopathy. J Muscle Res Cell Motil 2006; 8:1-8.
28. Udd B, Kööriönen H, Somer H: Muscular dystrophy with separate phenotypes in a large family. Muscle Nerve 1991; 14:1050-1058.
29. Udd B, Partanen J, Halonen P et al. Tibial muscular dystrophy-Late adult onset distal myopathy in 66 Finnish patients. Arch Neurol 1993; 50:604-608. (Pubitemid 23165589)
30. Udd B, Vihola A, Sarparanta J et al. Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J. Neurology 2005; 64:636-642. (Pubitemid 40261891)
31. de Seze J et al. The first European tibial muscular dystrophy family outside the Finnish population. Neurology 1998;51:1746-1748. (Pubitemid 28565269)
32. Van den Bergh P, Bouquiaux O, Verellen C et al. Tibial muscular dystrophy in a Belgian family. Annal Neurol 2003; 54:248-251. (Pubitemid 36909625)
33. Udd B et al. Imaging methods reveal unexpected patchy lesions in late onset distal myopathy. Neuromusc Disord 1991; 1:271-280.
34. Udd B et al. Nonvacuolar myopathy in a large family with both late adult onset distal myopathy and limb-girdle type muscular dystrophy. J Neurol Sci 1992; 113:214-221. (Pubitemid 23000569)
35. Haravuori H et al. (1998). Assignment of the tibial muscular dystrophy (TMD) locus on chromosome 2q31. Am J Hum Genet 62:620-626. (Pubitemid 28164619)
36. Udd B et al. Tibial muscular dystrophy-From clinical description to linkage on chromosome 2q31. Neuromusc Disord 1998; 8:327-332. (Pubitemid 28323057)
37. Sorimachi H, Kinbara K, Kimura S et al. Muscle-specific Calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence. J Biol Chem 1995; 270:31158-31162. (Pubitemid 26012203)
38. Haravuori H et al. Secondary calpain3 deficiency in 2q linked muscular dystrophy-Titin is the candidate gene. Neurology 2001; 56:869-877. (Pubitemid 32290803)
39. Houmeida A, Holt J, Tskhovrebova L et al. Studies of the interaction between titin and myosin. J Cell Biol 1995; 131:1471-1481. (Pubitemid 26001751)
40. Meredith C, Herrmann R, Parry C et al. Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause Laing early-onset distal myopathy (MPD1). Am J Hum Genet 2004; 75:703-708. (Pubitemid 39244785)
41. Beatham J, Gehmlich K, van de Ven P et al. Constitutive upregulations in KY deficient muscles suggest early titin involvement in the mechanism of pathogenesis. Neuromusc Disord 2006; 16:437-445.
42. Zastrow MS, Flaherty DB, Benian GM et al. Nuclear titin interacts with A- and B-type lamins in vitro and in vivo. J Cell Sci 2006; 119:239-49. (Pubitemid 43210693)
43. Edstrom L, Thornell L, Albo J et al. Myopathy with respiratory failure and typical myofibrillar lesions. J Neurol Sci 1990; 96:211-128.
44. Nicolao P, Xiang F, Gunnarsson L et al. Autosomal dominant myopathy with proximal weakness and early respiratory muscle involvement maps to chromosome 2q. Am J Hum Genet 1999; 64:788-792. (Pubitemid 30460421)
45. Xiang F, Nicolao P, Chapon F et al. A second locus for autosomal dominant myopathy with proximal muscle weakness and early respiratory muscle involvement: A likely chromosomal locus on 2q21. Neuromuscul Disord 1999; 9(5):308-312. (Pubitemid 29301711)
46. Mayans O, van der Ven P, Wilm M et al. Structural basis for activation of the titin kinase domain during myofibrillogenesis. Nature 1998; 395:863-869. (Pubitemid 28503420)
47. Amodeo P, Castiglione Morelli M, Strazzullo G et al. Kinase recognition by calmodulin: Modeling the interaction with the autoinhibitory region of human cardiac titin kinase. J Mol Biol 2001; 306:81-95. (Pubitemid 33027734)
48. Gomes MD, Lecker SH, Jagoe RT et al. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci 2001; 98(25):14440-14445. (Pubitemid 33121410)
49. Sotiropoulos A, Gineitis D, Copeland J et al. Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 1999; 98:159-169. (Pubitemid 29344904)
50. Sadoshima J and Izumo S. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: Potential involvement of an autocrine/paracrine mechanism. EMBO J 1993; 12:1681-1692. (Pubitemid 23112823)
51. Carson J, Schwartz R, Booth F. SRF and TEF-1 control of chicken skeletal alpha-actin gene during slow-muscle hypertrophy. Am J Physiol 1996; 270:1624-1633.
52. Salih MA, Al Rayess M, Cutshall S et al. A novel form of familial congenital muscular dystrophy in two adolescents. Neuropediatrics 1998; 29:289-293. (Pubitemid 29054562)
53. Taveau M, Bourg N, Sillon G et al. Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components. Mol Cell Biol 2003; 23:9127-9135. (Pubitemid 37499802)
54. Diaz BG, Moldoveanu T, Kuiper MJ et al. Insertion sequence 1 of muscle-specific calpain, p94, acts as an internal propeptide. J Biol Chem 2004; 279:27656-27666. (Pubitemid 38812607)
55. Fanin M, Nascimbeni AC, Fulizio L et al. The frequency of limb girdle muscular dystrophy 2A in northeastern Italy. Neuromuscul Disord 2005; 15:218-224. (Pubitemid 40255777)
56. Fardeau M, Eymard B, Mignard C et al. Chromosome 15-linked limb-girdle muscular dystrophy: Clinical phenotypes in Reunion Island and French metropolitan communities. Neuromuscul Disord 1996; 6:447-453. (Pubitemid 27052788)
57. Anderson LV, Harrison RM, Pogue R et al. Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies). Neuromuscul Disord 2000; 10:553-559.
58. Talim B, Ognibene A, Mattioli E et al. Normal calpain expression in genetically confirmed limb-girdle muscular dystrophy type 2A. Neurology 2001; 56:692-3. (Pubitemid 32210015)
59. Fanin M, Nascimbeni AC, Fulizio L et al. Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression. Am J Pathol 2003; 163:1929-1936. (Pubitemid 37310023)
60. Jenne DE, Kley RA, Vorgerd M et al. Limb girdle muscular dystrophy in a sibling pair with a homozygous Ser606Leu mutation in the alternatively spliced IS2 region of calpain 3. Biol Chem 2005; 386:61-67. (Pubitemid 40361452)
61. Lanzillo R, Aurino S, Fanin M et al. Early onset calpainopathy with normal non-functional calpain 3 level. Dev Med Child Neurol 2006; 48:304-306.
62. Saenz A, Leturcq F, Cobo AM et al. LGMD2A: Genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene. Brain 2005; 128:732-742. (Pubitemid 40516912)
63. Milic A, Daniele N, Lochmuller H et al. A third of LGMD2A biopsies have normal calpain 3 proteolytic activity as determined by an in vitro assay. Neuromuscul Disord 2007; 17(2):148-156.
64. Krahn M BR, Pecheux C, Hammouda EH et al. Screening of the CAPN3 gene in patients with possible LGMD2A. Clin Genet 2006; 69(5):444-449.
65. Ono Y, Shimada H, Sorimachi H et al. Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A. J Biol Chem 1998; 273:17073-8. (Pubitemid 28311741)
66. Duguez S, Bartoli M, Richard I. Calpain 3: A key regulator of the sarcomere? FEBS J 2006; 273 (15):3427-3436.
67. Cohen N, Kudryashova E, Kramerova I et al. Identification of putative in vivo substrates of calpain 3 by comparative proteomics of overexpressing transgenic and nontransgenic mice. Proteomics 2006; 6(22):6075-6084. (Pubitemid 44851392)
68. Richard I, Roudaut C, Marchand S et al. Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IkappaBalpha/nuclear factor kappaB pathway perturbation in mice. J Cell Biol 2000; 151(7):1583-1590. (Pubitemid 32047605)
69. Udd B and Griggs R. Distal myopathies. In: AG Engel, C Franzini-Armstrong (eds.) Myology 3rd edition. New York: McGraw-Hill, 2004; 1169-1185.
70. Pinotsis N, Petoukhov M, Lange S et al. Evidence for a dimeric assembly of two titin/telethonin complexes induced by the telethonin C-terminus. J Struct Biol 2006; 155(2):239-250. (Pubitemid 44278654)
71. Matsumoto Y, Hayashi T, Inagaki N et al. Functional analysis of titin/connectin N2-B mutations found in cardiomyopathy. J Muscle Res Cell Motil 2005; 26(6-8):367-374.
72. Bos JM, Poley RN, Ny M et al. Genotype-phenotype relationships involving hypertrophic cardiomyopathyassociated mutations in titin, muscle LIM protein and telethonin. Mol Genet Metab 2006; 88(1):78-85.